definiens: means, other than Appendix II Information, Know - Ho w bearing on methods, procedures and/or criteria involved in the design, formulation, selection, evaluation, or validation of one or more formulations for lipid - ba sed siRNA or miRNA products, where such methods, procedures and/or criteria include paramet ers bearing on one or more desired or anticipated behaviors of such product when used for therapeutic purposes and may also include parameters bearing on the manufacturability, stability, consistency, y ield, toxicity, or cost - effectiveness of such produ ct, as well as or other factors relevant to whether such p roduct may be desirable as a commercially marketed therapeutic . For clarity, the Formulation Design Kn ow - How does not include [ * ] . For example, if [COMPANY] is required to perform Technical Transfer w ith respect to a Product in accordance with Article 11 hereof, [COMPANY] will transfer all information an d intellectual property necessary for the Manufactu re of that Product in the same way that [COMPANY] Manufa ctured such Product at the time of Technical Transfer such that the transferee of such Technical Transfer can reproduce the Manufacturing Process of [COMPANY] for such Product, and it is understood t hat Formulation Design Know - How shall not be required to complete such Technical Transfer